To align our compensation closer to Company performance and to reward executive officers for
their contributions, starting in calendar year 2021 the STIP for our executive officers was changed so STIP payments for executive officers will only occur if Company performance is at least 80% of targeted performance (previously the minimum
threshold was 50%) and STIP award targets as a percentage of base salary were increased for executive officers to bring compensation closer to market levels.
In 2022, our executive officers received 200% of their target STIP incentive award that applied to calendar year 2021 performance with the
incentive award paid in early 2022 and is included below in the compensation amounts detailed for senior executives in 2022. The STIP achievement for calendar year 2022 was at 125% of the targeted performance for all STIP participants, including our
executive officers with payout occurred in March 2023 and these amounts will be included in the total compensation amount detailed for senior executives for 2023.
Long-Term Incentive Program (LTIP)
Our
LTIP is a share-based program that provides variable at risk compensation in the form of equity awards to executive officers to align their compensation with the growth in long-term value for our shareholders, to motivate executive
officers in achieving long-range goals and for long term retention. The Compensation Committee administers our 2019 Share Incentive Plan and determines the individuals eligible to receive awards, the types of awards, the number of common shares
subject to the awards, the value and timing of awards, and the other terms, conditions, performance criteria and restrictions on the awards. LTIP awards earned by our executive officers are subject to our claw-back policy in the event an award
payment was impacted by financial impropriety of the grantee.
For grants made in 2019 and prior years, the LTIP program consisted of 50%
share options and 50% restricted share grants, each of which vested 25% annually over four years. Additionally, we historically granted a reasonably consistent total number of shares year to year regardless of changes in the share price of the
Company common shares. For grants made since 2020, the Compensation Committee made substantial changes to our LTIP program in order to target granting awards with consistent annual initial dollar values based on an employees position and
salary grade. Further for Company vice presidents and above, the Compensation Committee determined that 75% of the annual award value would be in the form of performance-based restricted shares and 25% in the form of restricted share units that vest
one third per year over three years. The performance-based restricted shares have a cliff vesting three years after grant and the vesting percentage are solely based on the relative performance of the total shareholder return on the Companys
common shares compared to the Total Shareholder Return (rTSR) of the Russell 2000 index as measured over the vesting period. If the Companys rTSR is in the 50th percentile of the Russell index, 100% of the grant shall vest. If Company rTSR is
at the 25th percentile of the Russell index, 50% of the grant shall vest and if performance is at the 75th or greater percentile of the Russell index, 200% of the grant shall vest. None of the performance based restricted shares shall vest if
performance is below the 25th percentile of the Russell index.
The changes to the LTIP program make 75% of executive officers share
based compensation subject to the Companys share price performance relative to a market index and align executive compensation to shareholder returns so executive officers will not disproportionately benefit if the Company does not outperform
the market index.
Total Executive Compensation for 2022
The aggregate direct compensation we paid to our two senior executives (CEO and CFO) as a group for the year ended December 31, 2022 was
approximately $4,157,000, which included approximately $1,598,000 in STIP bonuses paid in 2022 (representing STIP earned for calendar year 2021 but paid in early 2022), approximately $1,353,000 in restricted stock awards that vested in 2022 from
grants made in prior years, and approximately $17,000 funds set aside or accrued to provide for retirement or similar benefits. This amount does not include expenses we incurred for other payments, including dues for professional and business
associations, health insurance, business travel and other expenses, which amounted to approximately $154,000. We did not pay our senior executives who also serve as directors any separate compensation for their directorship during 2022, other than
reimbursements for travel expenses.